{"id":13821,"date":"2016-04-12T00:02:10","date_gmt":"2016-04-12T04:02:10","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/busm-pathology\/?p=13821"},"modified":"2016-04-12T00:02:10","modified_gmt":"2016-04-12T04:02:10","slug":"departmental-seminar-april-15-2016","status":"publish","type":"post","link":"https:\/\/www.bumc.bu.edu\/busm-pathology\/2016\/04\/12\/departmental-seminar-april-15-2016\/","title":{"rendered":"Departmental Seminar &#8211; April 15, 2016"},"content":{"rendered":"<h3 style=\"text-align: center;\"><strong>Seminar Series: Spring 2016 ~~ Friday, April 15, 2016<\/strong><\/h3>\n<h3 style=\"text-align: center;\"><strong><span style=\"text-decoration: underline;\">2:00-3:00 PM<\/span><\/strong><\/h3>\n<p><strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/strong><\/p>\n<h2 style=\"text-align: center;\"><strong>\u201cBeyond and Into the Plasma Cell: New Approaches to AL Amyloidosis<\/strong><strong>\u201d<\/strong><\/h2>\n<p><strong>\u00a0<\/strong><\/p>\n<h3 style=\"text-align: center;\"><strong><span><span class=\"il\"><b>Raymond Comenzo, MD<br \/>\n<\/b><\/span><\/span><\/strong>Professor of\u00a0Medicine and Pathology<br \/>\nDirector of Blood Bank and Stem Cell Processing Laboratory<br \/>\nTufts University School of Medicine<\/h3>\n<p>&nbsp;<\/p>\n<p><strong><span style=\"text-decoration: underline;\">Location &amp; Time:<br \/>\n<\/span><\/strong>670 Albany Street<br \/>\nLobby Level #107\/108<br \/>\n<strong><span style=\"text-decoration: underline;\">2:00-3:00 PM<\/span><\/strong><\/p>\n<p><strong><span style=\"text-decoration: underline;\"><br \/>\n<\/span><\/strong><strong>Friday, April 15, 2016<br \/>\n<\/strong><strong>Target Audience: <\/strong>Faculty, Students, Residents, Greater Boston Scientific Community (advertised in MIT\u2019s Bulletin).<\/p>\n<p><strong>At the conclusion of this activity participants will be able to<\/strong><span>: 1)\u00a0report that the current therapeutic landscape for patients with systemic AL amyloidosis has exciting highlights and recurrent valleys of despair; 2) recall that only a minority of patients are eligible for stem cell transplant and a significant fraction of them do not achieve complete hematologic responses; and 3) state that the majority of patients are not eligible for stem cell transplant and, while many benefit from bortezomib-based therapies, 40% of those with advanced heart involvement die within a year of diagnosis<\/span>.<\/p>\n<p><strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><\/p>\n<p><strong>Course Director: <\/strong>Barbara Slack, PhD<\/p>\n<p>Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this educational activity for a\u00a0maximum of 1 AMA PRA Category 1 Credit(s)\u2122.\u00a0 Physicians should only claim credit commensurate with the extent of their participation in the activity.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Seminar Series: Spring 2016 ~~ Friday, April 15, 2016 2:00-3:00 PM \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u201cBeyond and Into the Plasma Cell: New Approaches to AL Amyloidosis\u201d \u00a0 Raymond Comenzo, MD Professor of\u00a0Medicine and Pathology Director of Blood Bank and Stem Cell Processing Laboratory Tufts University School of Medicine &nbsp; Location &amp; Time: [&hellip;]<\/p>\n","protected":false},"author":9112,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[16418],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/posts\/13821"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/users\/9112"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/comments?post=13821"}],"version-history":[{"count":2,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/posts\/13821\/revisions"}],"predecessor-version":[{"id":13823,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/posts\/13821\/revisions\/13823"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/media?parent=13821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/categories?post=13821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/tags?post=13821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}